Banque Pictet & Cie’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $11.7M | Sell |
23,496
-5,054
| -18% | -$2.24M | 0.07% | 97 |
|
|
2026
Q1 | $12.7M | Buy |
28,550
+4,222
| +17% | +$1.97M | 0.09% | 87 |
|
|
2025
Q4 | $11M | Buy |
24,328
+15,470
| +175% | +$6.67M | 0.06% | 105 |
|
|
2025
Q3 | $3.47M | Sell |
8,858
-8,079
| -48% | -$3.38M | 0.02% | 186 |
|
|
2025
Q2 | $7.54M | Buy |
16,937
+5,564
| +49% | +$2.56M | 0.05% | 124 |
|
|
2025
Q1 | $5.51M | Sell |
11,373
-670
| -6% | -$312K | 0.04% | 144 |
|
|
2024
Q4 | $4.85M | Buy |
12,043
+788
| +7% | +$365K | 0.03% | 155 |
|
|
2024
Q3 | $5.23M | Sell |
11,255
-14,009
| -55% | -$6.73M | 0.04% | 143 |
|
|
2024
Q2 | $11.8M | Buy |
25,264
+3,024
| +14% | +$1.31M | 0.11% | 81 |
|
|
2024
Q1 | $9.3M | Sell |
22,240
-970
| -4% | -$410K | 0.09% | 97 |
|
|
2023
Q4 | $9.44M | Sell |
23,210
-3,354
| -13% | -$1.24M | 0.08% | 92 |
|
|
2023
Q3 | $9.24M | Sell |
26,564
-1,558
| -6% | -$545K | 0.11% | 89 |
|
|
2023
Q2 | $9.9M | Buy |
28,122
+1,215
| +5% | +$409K | 0.09% | 109 |
|
|
2023
Q1 | $8.48M | Buy |
26,907
+2,639
| +11% | +$792K | 0.08% | 115 |
|
|
2022
Q4 | $7.01M | Sell |
24,268
-22,285
| -48% | -$6.79M | 0.07% | 135 |
|
|
2022
Q3 | $13.5M | Sell |
46,553
-14,145
| -23% | -$4.07M | 0.15% | 82 |
|
|
2022
Q2 | $17.1K | Sell |
60,698
-24,898
| -29% | -$6.66M | 0.17% | 71 |
|
|
2022
Q1 | $22.3M | Sell |
85,596
-6,905
| -7% | -$1.64M | 0.17% | 69 |
|
|
2021
Q4 | $20.3M | Buy |
92,501
+57,611
| +165% | +$11.2M | 0.15% | 80 |
|
|
2021
Q3 | $6.33M | Buy |
34,890
+980
| +3% | +$191K | 0.07% | 127 |
|
|
2021
Q2 | $6.84M | Sell |
33,910
-6,762
| -17% | -$1.41M | 0.08% | 122 |
|
|
2021
Q1 | $8.74M | Buy |
40,672
+1,456
| +4% | +$320K | 0.11% | 99 |
|
|
2020
Q4 | $9.27M | Buy |
39,216
+37,055
| +1,715% | +$8.5M | 0.13% | 88 |
|
|
2020
Q3 | $588K | Buy |
2,161
+316
| +17% | +$87.2K | 0.01% | 245 |
|
|
2020
Q2 | $536K | Buy |
1,845
+140
| +8% | +$38K | 0.01% | 256 |
|
|
2020
Q1 | $406K | Hold |
1,705
| – | – | 0.01% | 277 |
|
|
2019
Q4 | $373K | Hold |
1,705
| – | – | 0.01% | 308 |
|
|
2019
Q3 | $289K | Hold |
1,705
| – | – | 0.01% | 310 |
|
|
2019
Q2 | $313K | Hold |
1,705
| – | – | 0.01% | 289 |
|
|
2019
Q1 | $314K | Sell |
1,705
-560
| -25% | -$103K | 0.01% | 290 |
|
|
2018
Q4 | $375K | Sell |
2,265
-940
| -29% | -$163K | 0.01% | 289 |
|
|
2018
Q3 | $618K | Buy |
3,205
+1,500
| +88% | +$267K | 0.01% | 274 |
|
|
2018
Q2 | $290K | Hold |
1,705
| – | – | 0.01% | 318 |
|
|
2018
Q1 | $278K | Buy |
+1,705
| New | +$278K | 0.01% | 332 |
|
Other funds holding VRTX
Banque Pictet & Cie's VRTX Position: Q2 2026 in Review
Banque Pictet & Cie reduced its Vertex Pharmaceuticals (VRTX) stake by 18% in Q2 2026, selling an estimated $2.24M and leaving 23,496 shares worth $11.7M. The position accounts for 0.07% of the portfolio, ranked #97.
Banque Pictet & Cie first reported a position in VRTX in Q1 2018 and has held it in 34 quarters since. The position peaked at $22.3M in Q1 2022. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Banque Pictet & Cie held 23,496 shares of Vertex Pharmaceuticals worth $11.7M as of Q2 2026.
- Banque Pictet & Cie sold 5,054 Vertex Pharmaceuticals shares in Q2 2026, an estimated $2.24M.
- Vertex Pharmaceuticals made up 0.07% of Banque Pictet & Cie's portfolio in Q2 2026, its #97 holding.
- Banque Pictet & Cie first reported a position in Vertex Pharmaceuticals in Q1 2018 and has held it in 34 quarters since.
- Banque Pictet & Cie's Vertex Pharmaceuticals position peaked at $22.3M in Q1 2022.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Banque Pictet & Cie's 13F filing for Q2 2026, filed 24 Jul 2026.